Nuveen, LLC Moderna, Inc. Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Nuveen, LLC holds 688,196 shares of MRNA stock, worth $17.7 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
688,196Holding current value
$17.7 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding MRNA
# of Institutions
904Shares Held
243MCall Options Held
19.1MPut Options Held
24.3M-
Vanguard Group Inc Valley Forge, PA40.4MShares$1.04 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$657 Million0.07% of portfolio
-
Baillie Gifford & CO24.9MShares$641 Million0.64% of portfolio
-
State Street Corp Boston, MA17.6MShares$452 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA7.46MShares$192 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $10.1B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...